Oxford’s new malaria R21/Matrix-M vaccine approved by WHO

Comment on this storyComment The World Health Organization has approved a new anti-malaria vaccine, which will offer countries a cheap and more accessible option to combat one of the leading causes of child deaths in Africa. Developed by Oxford University, the R21/Matrix-M vaccine is the second vaccine to be recommended by the WHO, it said … Read more